Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 102 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1011 11.4 months Metastatic melanoma 4 Chemotherapy
Immunotherapy
University of California Irvine Medical Center United States 10/2011
Treatment Details: Patients: This phase 2 study involved 52 metastatic melanoma patients with a median age of 62 years; 71.1% were male. Treatment: Patients were treated with the chemotherapy agents docet
 
1012 11.4 months Advanced NSCLC 4 Biologic therapy
Hospices Civils de Lyon France 10/2012
Treatment Details: Patients: This phase 3 study involved patients with advanced non-small-cell lung cancer patients, previously treated with cisplatin and gemcitabine, who were divided into two treatment grou
 
1013 11.3 months Metastatic colorectal cancer 5 Chemotherapy
Yonsei University College of Medicine Korea 10/2011
Treatment Details: Patients: This phase II study involved 48 elderly or frail patients with metastatic colorectal cancer. The median age was 73 years (range of 65–85 years old) and 54% were male. Treatmen
 
1014 11.3 months Metastatic, castration-resistant prostate cancer 4 Chemotherapy
BC Cancer Agency Canada 1/2012
Treatment Details: Patients: This phase 2 study involved 83 metastatic castration-resistant prostate cancer patients who had been previously treated with docetaxel. The median patient age was 67 years. Tr
 
1015 11.3 months NHL 5 Biologic therapy
Radiation
Korea Cancer Center Hospital Korea 6/2011
Treatment Details: Patients: This study involved 24 non-Hodgkin’s lymphoma patients with a median age of 63 years; 75% were male. Treatment: Patients received radioimmunotherapy with the biologic therapy
 
1016 11.3 months Metastatic triple negative breast cancer 4 Biologic therapy
Chemotherapy
Washington University School of Medicine United States 1/2013
Treatment Details: Patients: This phase 2 study involved 25 female metastatic triple negative breast cancer (negative for mutations in estrogen receptor, progesterone receptor, and HER2) patients who had rece
 
1017 11.3 months Metastatic urothelial carcinoma 4 Chemotherapy
Korea University College of Medicine Korea 4/2014
Treatment Details: Patients: This study involved 28 metastatic urothelial carcinoma patients who were previously treated with gemcitabine and cisplatin. The median patient age was 64 years and 75% were male.
 
1018 11.3 months Advanced melanoma 4 Chemotherapy
Churchill Hospital United Kingdom 2/2014
Treatment Details: Patients: This phase 2 study involved advanced melanoma patients with the wild-type BRAF gene who were divided into two different treatment groups. Group A consisted of 41 patients with a m
 
1019 11.3 months Non-Squamous NSCLC 5 Biologic therapy
Chemotherapy
Hospital Universitario Doce de Octubre Spain 3/2015
Treatment Details: Patients: This phase 3 study involved untreated advanced non-squamous non- small-cell lung cancer patients who were divided into two separate treatment groups. Group A consisted of 315 pat
 
1020 11.3 months Malignant Mesothelioma 5 University Hospital of Siena Italy 4/2015
Treatment Details: Patients: This phase 2 study involved 29 malignant mesothelioma patients who had received prior chemotherapy. The median patient age was 65 years; no gender information was provided. Tr
 
Page 102 of 187  | Previous Page  | Next Page